Alfardan Medical with Northwestern Medicine Select Allscripts

AllscriptsAllscripts (NASDAQ: MDRX) announced that Alfardan Group, one of the leading family-owned conglomerates in Qatar and Chicago-based Northwestern Medicine have selected Allscripts to provide ambulatory care services for the launch of its new project, Alfardan Medical with Northwestern Medicine. The project is a part of Allscripts expansion in the Middle East and will provide ambulatory care services including Sunrise™ Ambulatory, Sunrise™ Surgery, Sunrise™ Radiology, Allscripts® Clinical Performance Management, Allscripts Lab™ and iPro Anesthesia™.

Based in Burj Alfardan, Lusail, Alfardan Medical with Northwestern Medicine is the first of Alfardan Group's investments in the health sector, as part of its social responsibility toward the State of Qatar and its vision to develop projects that will contribute to the realisation of the Qatar National Vision 2030. Alfardan Medical with Northwestern Medicine will offer high quality healthcare and a range of multidisciplinary medical specialisations in a unique clinical environment.

Used by healthcare organsations across the globe, Allscripts Sunrise is a fully integrated electronic health record that connects all aspects of care, including ambulatory, surgical, radiology, and laboratory services. Built to enable efficient and safe care, Sunrise is a physician-friendly, evidence-based single platform with integrated analytics that helps deliver true personalised medicine. Sunrise supports all core care venues across the enterprise by delivering a single patient record, and features patient-centric capabilities that increase access and convenience for the consumer.

"Alfardan Group has built its reputation on offering our clients a lifestyle in keeping with the quality and premium services that they value," said Omar Hussain Alfardan, President and Chief Executive Officer of Alfardan Group. "We believe Allscripts is the suitable partner to help us deliver world-class integrated healthcare to Qatar."

"We are pleased to have the opportunity to partner with Alfardan Group and Northwestern Medicine in its new project," said Paul M. Black, Chief Executive Officer of Allscripts. "With the help of this new partnership in the Middle East, we can demonstrate the value of Allscripts commitment to open, connected communities of care to its people and across the globe."

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations.

About Alfardan Medical with Northwestern Medicine (AMNM)

Alfardan Medical with Northwestern Medicine (AMNM) is an ambulatory care center that provides high quality, multidisciplinary medical specializations, based in Burj Alfardan, Lusail.

AMNM is an international collaboration between Alfardan Group and Northwestern Medicine (Chicago, U.S.A.). They each share a vision and a set of guiding values for the establishment, execution and operation of AMNM.

Most Popular Now

Elsevier Adds to its Extensive Free Reso…

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and...

Cancer Care Model could Help Us Cope wit…

As the UK government looks for an exit strategy to Britain's COVID-19 lockdown a nanomedicine expert from The University of Manchester believes a care model usually applied to cancer patients...

An EU Approach for Efficient Contact Tra…

EU Members States, supported by the Commission, have developed an EU toolbox for the use of mobile applications for contact tracing and warning in response to the coronavirus pandemic. This...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Telemedicine Transforms Response to COVI…

A rapid increase in "virtual" visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...